Spain to lift suspension of AstraZeneca vaccine for second dose in people under 60

2 minute read
Register now for FREE unlimited access to Reuters.com

MADRID, May 19 (Reuters) - Spain will allow people under age 60 who have received a first dose of AstraZeneca Plc's (AZN.L) COVID-19 vaccine to receive their second inoculation either with the AstraZeneca drug or with Pfizer Inc's (PFE.N) vaccine, Health Minister Carolina Darias said on Wednesday.

"It is an exception due to the extraordinary circumstances," Darias told a news conference.

Until now, those who had received their first dose of the AstraZeneca vaccine were in limbo because the government suspended that vaccine in March, for people under 60, due to blood-clot concerns.

Register now for FREE unlimited access to Reuters.com

The new policy will affect about 1.5 million Spaniards who have already received their first AstraZeneca dose.

A study by the government's Carlos III Health Institute found that giving a dose of the vaccine developed by Pfizer and BioNTech SE (22UAy.DE) to people who already received a first shot of the AstraZeneca vaccine was safe and effective. read more

Graphic: COVID-19 global vaccination tracker: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/vaccination-rollout-and-access/

Register now for FREE unlimited access to Reuters.com
Reporting by Belén Carreño in Madrid Editing by Matthew Lewis

Our Standards: The Thomson Reuters Trust Principles.